Financial Network Wealth Advisors’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.89K Hold
200
– – ﹤0.01% 589
2026
Q2
$6.86K Hold
200
– – 0.01% 537
2026
Q1
$4.77K Hold
200
– – ﹤0.01% 554
2025
Q4
$5.54K Hold
200
– – 0.01% 532
2025
Q3
$4.85K Hold
200
– – 0.01% 540
2025
Q2
$3.4K Hold
200
– – ﹤0.01% 565
2025
Q1
$3.91K Buy
+200
New +$5.24K 0.01% 521

Other funds holding BEAM

Financial Network Wealth Advisors's BEAM Position: Q3 2026 in Review

Financial Network Wealth Advisors held its Beam Therapeutics (BEAM) position steady in Q3 2026 at 200 shares worth $4.89K. The position accounts for ﹤0.01% of the portfolio, ranked #589.

Financial Network Wealth Advisors first reported a position in BEAM in Q1 2025 and has held it in 7 quarters since. The position peaked at $6.86K in Q2 2026. 261 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Financial Network Wealth Advisors held 200 shares of Beam Therapeutics worth $4.89K as of Q3 2026.
  • Financial Network Wealth Advisors left its Beam Therapeutics share count unchanged in Q3 2026.
  • Beam Therapeutics made up ﹤0.01% of Financial Network Wealth Advisors's portfolio in Q3 2026, its #589 holding.
  • Financial Network Wealth Advisors first reported a position in Beam Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • Financial Network Wealth Advisors's Beam Therapeutics position peaked at $6.86K in Q2 2026.
  • 261 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Financial Network Wealth Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.